South & Central America Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
The South & Central America Point of Care (POC) Diagnostics Market is projected to grow significantly, reaching an estimated US$ 6,924.0 million by 2031, up from US$ 3,508.9 million in 2024. This growth represents a compound annual growth rate (CAGR) of 10.2% from 2025 to 2031. The market encompasses key countries such as Brazil and Argentina, which play a vital role in the global healthcare landscape.
Several factors are driving the anticipated growth of the POC diagnostics market in South & Central America. The rising prevalence of chronic diseases, including diabetes, cardiovascular disorders, and various infectious diseases, has created a pressing demand for rapid, efficient, and accessible diagnostic solutions. Furthermore, there is an increasing awareness of the importance of early disease detection and the necessity for improved healthcare delivery, particularly in remote areas. This awareness is further bolstered by government initiatives aimed at enhancing healthcare infrastructure and accessibility to diagnostic services.
Major medical device companies are actively investing in the region, engaging in strategic partnerships, launching new products, and innovating technologies to strengthen their market presence. These efforts are expected to contribute significantly to the growth of the POC diagnostics market.
Market Segmentation Analysis
The South & Central America POC diagnostics market can be segmented by product type, purchase mode, sample type, and end user.
1. By Product: The market is divided into several categories, including Glucose Monitoring, Infectious Disease Testing, Cardio Metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and others. In 2024, Glucose Monitoring held the largest market share, with sub-segments such as Blood Glucose Meters, Lancets, and Strips, where Strips were the most dominant.
2. Infectious Disease Testing: This segment includes HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Testing, and others, with Respiratory Infection Testing leading the market share in 2024.
3. Cardio Metabolic Testing: This includes tests like Cardiac Troponin (cTn) and Myoglobin Tests, with Cardiac Troponin Tests being the most significant in terms of market share.
4. Purchase Mode: The market is segmented into Over-the-Counter (OTC) and Prescription modes, with Prescription holding the larger share.
5. Sample Type: The market is categorized into Blood, Urine, and others, with Blood samples being the most prevalent.
6. End User: The market is divided into Healthcare Facilities, Homecare, and others, with Healthcare Facilities dominating the market.
7. Healthcare Facilities: This includes Hospitals, Clinics, and Diagnostic Centers, with Diagnostic Centers holding the largest share in 2024.
Market Outlook
The POC diagnostics market is witnessing a shift towards emerging economies, particularly in countries like Brazil, which is experiencing a high burden of chronic diseases such as diabetes and cancer. Brazil, as the largest economy in South & Central America, has a healthcare system that is divided into public and private sectors. Despite local manufacturing being limited to consumables, Brazil imports a significant number of medical devices, indicating a reliance on international technology and innovation.
The increasing incidence of chronic diseases, particularly diabetes, is prompting both government and private organizations to enhance awareness and improve healthcare delivery. For instance, the International Diabetes Federation reported approximately 15.7 million diabetes cases in Brazil in 2023, highlighting the urgent need for effective diagnostic solutions.
Moreover, the rise in hospital-acquired infections (HAIs) poses a significant challenge to public health in Brazil, necessitating improved infection control measures and healthcare quality. The market is also benefiting from advancements in technology, including nanotechnology and genomics, which are paving the way for more sophisticated and personalized diagnostic solutions.
Key Players
The competitive landscape of the South & Central America POC diagnostics market includes prominent companies such as Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are focusing on strategies such as product innovation, expansion, and mergers and acquisitions to enhance their market share and deliver innovative solutions to consumers.
In conclusion, the South & Central America POC diagnostics market is poised for substantial growth driven by increasing chronic disease prevalence, technological advancements, and strategic investments by key players. The focus on improving healthcare delivery and accessibility will further support the expansion of this vital market.
Several factors are driving the anticipated growth of the POC diagnostics market in South & Central America. The rising prevalence of chronic diseases, including diabetes, cardiovascular disorders, and various infectious diseases, has created a pressing demand for rapid, efficient, and accessible diagnostic solutions. Furthermore, there is an increasing awareness of the importance of early disease detection and the necessity for improved healthcare delivery, particularly in remote areas. This awareness is further bolstered by government initiatives aimed at enhancing healthcare infrastructure and accessibility to diagnostic services.
Major medical device companies are actively investing in the region, engaging in strategic partnerships, launching new products, and innovating technologies to strengthen their market presence. These efforts are expected to contribute significantly to the growth of the POC diagnostics market.
Market Segmentation Analysis
The South & Central America POC diagnostics market can be segmented by product type, purchase mode, sample type, and end user.
1. By Product: The market is divided into several categories, including Glucose Monitoring, Infectious Disease Testing, Cardio Metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and others. In 2024, Glucose Monitoring held the largest market share, with sub-segments such as Blood Glucose Meters, Lancets, and Strips, where Strips were the most dominant.
2. Infectious Disease Testing: This segment includes HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Testing, and others, with Respiratory Infection Testing leading the market share in 2024.
3. Cardio Metabolic Testing: This includes tests like Cardiac Troponin (cTn) and Myoglobin Tests, with Cardiac Troponin Tests being the most significant in terms of market share.
4. Purchase Mode: The market is segmented into Over-the-Counter (OTC) and Prescription modes, with Prescription holding the larger share.
5. Sample Type: The market is categorized into Blood, Urine, and others, with Blood samples being the most prevalent.
6. End User: The market is divided into Healthcare Facilities, Homecare, and others, with Healthcare Facilities dominating the market.
7. Healthcare Facilities: This includes Hospitals, Clinics, and Diagnostic Centers, with Diagnostic Centers holding the largest share in 2024.
Market Outlook
The POC diagnostics market is witnessing a shift towards emerging economies, particularly in countries like Brazil, which is experiencing a high burden of chronic diseases such as diabetes and cancer. Brazil, as the largest economy in South & Central America, has a healthcare system that is divided into public and private sectors. Despite local manufacturing being limited to consumables, Brazil imports a significant number of medical devices, indicating a reliance on international technology and innovation.
The increasing incidence of chronic diseases, particularly diabetes, is prompting both government and private organizations to enhance awareness and improve healthcare delivery. For instance, the International Diabetes Federation reported approximately 15.7 million diabetes cases in Brazil in 2023, highlighting the urgent need for effective diagnostic solutions.
Moreover, the rise in hospital-acquired infections (HAIs) poses a significant challenge to public health in Brazil, necessitating improved infection control measures and healthcare quality. The market is also benefiting from advancements in technology, including nanotechnology and genomics, which are paving the way for more sophisticated and personalized diagnostic solutions.
Key Players
The competitive landscape of the South & Central America POC diagnostics market includes prominent companies such as Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are focusing on strategies such as product innovation, expansion, and mergers and acquisitions to enhance their market share and deliver innovative solutions to consumers.
In conclusion, the South & Central America POC diagnostics market is poised for substantial growth driven by increasing chronic disease prevalence, technological advancements, and strategic investments by key players. The focus on improving healthcare delivery and accessibility will further support the expansion of this vital market.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.2 PEST Analysis
5. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Point of Care Diagnostics Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 South & Central America
15.1.1 South & Central America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 South & Central America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 Brazil: South & Central America Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 Brazil: South & Central America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 Brazil: South & Central America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 Brazil: South & Central America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 Brazil: South & Central America Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 Brazil: South & Central America Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 Brazil: South & Central America Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 Brazil: South & Central America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Argentina: South & Central America Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Argentina: South & Central America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Argentina: South & Central America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Argentina: South & Central America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Argentina: South & Central America Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Argentina: South & Central America Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Argentina: South & Central America Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Argentina: South & Central America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.2 PEST Analysis
5. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
6.1 South & Central America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Point of Care Diagnostics Market Forecast and Analysis
7. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. SOUTH & CENTRAL AMERICA POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 South & Central America
15.1.1 South & Central America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 South & Central America Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 Brazil: South & Central America Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 Brazil: South & Central America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 Brazil: South & Central America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 Brazil: South & Central America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 Brazil: South & Central America Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 Brazil: South & Central America Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 Brazil: South & Central America Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 Brazil: South & Central America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Argentina: South & Central America Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Argentina: South & Central America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Argentina: South & Central America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Argentina: South & Central America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Argentina: South & Central America Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Argentina: South & Central America Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Argentina: South & Central America Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Argentina: South & Central America Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 Rest of South & Central America: South & Central America Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. South & Central America Point of Care Diagnostics Market Segmentation
Table 3. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 1. South & Central America Point of Care Diagnostics Market Segmentation
Table 3. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
LIST OF FIGURES
Figure 1. South & Central America Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. South & Central America Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South & Central America Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. South & Central America Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. South & Central America Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. South & Central America Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. South & Central America Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. South & Central America Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. South & Central America Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. South & Central America Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. South & Central America Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South & Central America Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. South & Central America Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. South & Central America Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. South & Central America Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. South & Central America Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. South & Central America Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. South & Central America Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. Brazil: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Argentina: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. Rest of South & Central America: South & Central America Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
